A systematic pipeline of protein structure selection for computer‐aided drug discovery: A case study on T790M/L858R mutant EGFR structures
Protein Science · 2023
DOI: 10.1002/pro.4740 ↗At a glance
Journal article in Protein Science, 2023. Written by Agneesh Pratim Das and 3 co-authors. Institution: Bioinformatics Division, ICMR-National Institute of Cancer Prevention and Research, Noida, Uttar Pradesh, India. Major MEDLINE topics: ErbB Receptors, Lung Neoplasms. Cited 6 times so far (Crossref); 46 references. The full text is freely available in PubMed Central.
Abstract (original language)
Virtual screening (VS) is a routine method to evaluate chemical libraries for lead identification. Therefore, the selection of appropriate protein structures for VS is an essential prerequisite to identify true actives during docking. But the presence of several crystal structures of the same protein makes it difficult to select one or few structures rationally for screening. Therefore, a computational prioritization protocol has been developed for shortlisting crystal structures that identify true active molecules with better efficiency. As identification of small‐molecule inhibitors is an important clinical requirement for the T790M/L858R (TMLR) EGFR mutant, it has been selected as a case study. The approach involves cross‐docking of 21 co‐crystal ligands with all the structures of the same protein to select structures that dock non‐native ligands with lower RMSD. The cross docking performance was then correlated with ligand similarity and binding‐site conformational similarity. Eventually, structures were shortlisted by integrating cross‐docking performance, and ligand and binding‐site similarity. Thereafter, binding pose metadynamics was employed to identify structures having stable co‐crystal ligands in their respective binding pockets. Finally, different enrichment metrics like BEDROC, RIE, AUAC, and EF 1% were evaluated leading to the identification of five TMLR structures ( 5HCX , 5CAN , 5CAP , 5CAS , and 5CAO ). These structures docked a number of non‐native ligands with low RMSD, contain structurally dissimilar ligands, have conformationally dissimilar binding sites, harbor stable co‐crystal ligands, and also identify true actives early. The present approach can be implemented for shortlisting protein targets of any other important therapeutic kinases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Bioinformatics Division, ICMR-National Institute of Cancer Prevention and Research, Noida, Uttar Pradesh, India.
- Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India.
- Schrödinger India Private Limited, Bengaluru, Karnataka, India.
ORCID profiles: Subhash M Agarwal
Cite
APA
Das, A. P., Nandekar, P., Mathur, P., & Agarwal, S. M. (2023). A systematic pipeline of protein structure selection for computer‐aided drug discovery: A case study on T790M/L858R mutant EGFR structures. Protein Science. https://doi.org/10.1002/pro.4740
Vancouver
Das AP, Nandekar P, Mathur P, Agarwal SM. A systematic pipeline of protein structure selection for computer‐aided drug discovery: A case study on T790M/L858R mutant EGFR structures. Protein Science. 2023. doi:10.1002/pro.4740
BibTeX
@article{Das2023,
author = {Das, Agneesh Pratim and Nandekar, Prajwal and Mathur, Puniti and Agarwal, Subhash M},
title = {A systematic pipeline of protein structure selection for computer‐aided drug discovery: A case study on T790M/L858R mutant EGFR structures},
journal = {Protein Science},
year = {2023},
doi = {10.1002/pro.4740}
}
EUVIMED